• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
The 2011 Leading Pharmaceutical Companies Strategic Directions Product Image

The 2011 Leading Pharmaceutical Companies Strategic Directions

  • ID: 1081227
  • October 2010
  • 45 Pages
  • Venture Planning Group (VPG)

FEATURED COMPANIES

  • AstraZeneca
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Novartis
  • MORE

For each company, the report provides insightful strategic assessments, including:<ul><li>Major strengths and weaknesses.</li><li>Business, new product development, and marketing objectives and strategies.</li><li>Anticipated acquisitions, joint ventures and divestitures.</li></ul>The companies analyzed in the report:        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   WyethContains 45 pages

- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos